Recall Record

Fayetteville, AR, United States

OurPharma LLC recalls

4 recalls recorded since 2018, most recently on 3 September 2026. 1 is listed as ongoing. Status and classification are as published by the FDA.

Recalls4
Ongoing (FDA)1
Terminated or completed3
Class I (FDA)0

Ongoing Class II Drugs

Recall started
3 September 2026
Reason
Labeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag expiry (07/31/2026 and 11/30/2026) and the product expiry (12/09/2026).
Distribution
Nationwide within the U.S
Initiated
Voluntary: Firm initiated
Recall number
D-0864-2026

Terminated Class III Drugs

Recall started
15 April 2025
Terminated
6 March 2026
Reason
Superpotent Drug: Assay/potency result for hydromorphone HCl in the compounded stability lot was higher than specification..
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall number
D-0385-2025

Terminated Class III Drugs

Recall started
13 January 2023
Terminated
20 September 2024
Reason
Short Fill: Underfilled units.
Distribution
IL and MO
Initiated
Voluntary: Firm initiated
Recall number
D-0172-2023

Terminated Class II Drugs

Recall started
29 November 2022
Terminated
20 September 2024
Reason
Underfilled units.
Distribution
MO
Initiated
Voluntary: Firm initiated
Recall number
D-0078-2023

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.